| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $46K | +939.7% |
| R&D Expense | $515K | — |
| SG&A Expense | $992K | +44.0% |
| Operating Income | -$12.2M | -12.8% |
| Interest Expense | $127 | +0.0% |
| Net Income | -$12.1M | -12.1% |
| EPS (Basic) | -$0.60 | +15.5% |
| EPS (Diluted) | -$0.60 | +15.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $11.0M | — |
| Accounts Receivable | $384 | +38.1% |
| Current Assets | $12.9M | -37.4% |
| Total Assets | $13.1M | -37.0% |
| Current Liabilities | $473K | -18.4% |
| Total Liabilities | $557K | -23.8% |
| Stockholders' Equity | $12.6M | -37.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.3M | +14.1% |
| Capital Expenditures | $44K | -20.6% |
| Investing Cash Flow | -$11.2M | — |
| Financing Cash Flow | $1K | -100.0% |
| Free Cash Flow | -$7.3M | +14.2% |